Skip to main content
SpringerLink
Log in

Near-adult height in male kidney transplant recipients started on growth hormone treatment in late puberty

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Growth retardation and its impact on adult height is considered to be one of the most common complications in patients with chronic kidney disease (CKD). Treatment with recombinant human growth hormone (rhGH) has been effective in improving growth in kidney transplantation (KTx) patients, but little data are available on adult height in patients who began rhGh treatment in late puberty.

Methods

Near-adult height was evaluated in 13 KTx patients treated with rhGH [growth hormone group (GHGr); dose 9.33 mg/m2 per week] for a period of at least 18 months. At initiation of rhGH treatment, testicular volume was >8 ml and serum testosterone was >1 ng/ml compared with the control group (CGr) of ten KTx patients who did not receive rHGH. All subjects were of similar chronological age and bone age and had similar creatinine clearance (CrCl) levels, cumulative corticoid dose, height standard deviation score (SDS), target height SDS, and target height:initial height at the beginning of the study.

Results

Near-adult height was significantly greater in the GHGr than in the CGr (−1.8 ± 0.8 vs. −2.9 ± 1.1; p = 0.018). The difference between initial height and near-adult height in the GHGr revealed a significant height gain (initial height −3.1 ± 1.1; near-adult height −1.8 ± 0.8 SDS, respectively; delta 1.2 ± 0.3; p = 0.021). The CrCl level was not significantly different between the GHGr and CGr at either at study initiation or when attaining near-adult height (p = 0.74 and p = 0.23, respectively).

Conclusions

Treatment with rhGH was effective in improving adult height in KTx patients who began treatment in late puberty, without any effect on renal function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ugarte F, Irarrazabal C, Oh J, Dettmar A, Ceballos ML, Rojo A, Ibacache MJ, Suazo C, Lozano M, Delgado I, Cavada G, Azocar M, Delucchi A, Cano F (2016) Impaired phosphorylation of JAK2-STAT5b signaling in fibroblasts from uremic children. Pediatr Nephrol 31:965–974

    Article  PubMed  Google Scholar 

  2. Schaefer F, Veldhuis JD, Robertson WR, Dunger D, Schärer K (1994) Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic renal failure. Cooperative study group on pubertal development in chronic renal failure. Kidney Int 45:1465–1476

    Article  CAS  PubMed  Google Scholar 

  3. Fine RN (2007) Management of growth retardation in pediatric recipients of renal allografts. Nat Clin Pract Nephrol 3:318–324

    Article  PubMed  Google Scholar 

  4. Gil S, Vaiani E, Guercio G, Ciaccio M, Turconi A, Delgado N, Rivarola MA, Belgorosky A (2012) Effectiveness of rhGH treatment on final height of renal-transplant recipients in childhood. Pediatr Nephrol 27:1005–1012

    Article  PubMed  Google Scholar 

  5. Nissel R, Lindberg A, Mehls O, Haffner D, Pfizer International Growth Database (KIGS) International Board (2008) Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease. J Clin Endocrinol Metab 93:1359–1365

    Article  CAS  PubMed  Google Scholar 

  6. Hokken-Koelega A, Stijnen T, de Ridder MA, de Muinck Keizer-Schrama SM, Wolff ED, de Jong MC, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SL (1994) Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 343:1313–1317

    Article  CAS  PubMed  Google Scholar 

  7. Maxwell H, Rees L (1998) Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. Arch Dis Child 79:481–487

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Janssen F, Van Damme-Lombaerts R, Van Dyck M, Hall M, Schurmans T, Herman J, Hooghe L, Van Damme B (1997) Impact of growth hormone treatment on a Belgian population of short children with renal allografts. Pediatr Transplant 1:190–196

    CAS  PubMed  Google Scholar 

  9. Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity, and weight velocity British children 1965. Arch Dis Child 219:454–471

    Article  Google Scholar 

  10. Guerlich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press, Stanford

    Google Scholar 

  11. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590

    Article  CAS  PubMed  Google Scholar 

  12. Fujii H, Chikamoto H, Akioka Y, Hattori M (2014) Final adult height in kidney recipients who underwent highly successful transplantation as children: A single-center experience. Clin Exp Nephrol 18:515–520

    Article  PubMed  Google Scholar 

  13. Mehls O, Wühl E, Tönshoff B, Schaefer F, Nissel R, Haffner D (2008) Growth hormone treatment in short children with chronic kidney disease. Acta Paediatr 97:1159–1164

    Article  CAS  PubMed  Google Scholar 

  14. Fine RN, Stablein D (2005) Long-term use of recombinant human growth hormone in pediatric allograft recipients: A report of the NAPRTCS transplant registry. Pediatr Nephrol 20:404–408

    Article  PubMed  Google Scholar 

  15. Bérard E, André JL, Guest G, Berthier F, Afanetti A, Cochat P, Michel Broyer M, French Society for Pediatric Nephrology (2008) Long-term results of rhGH treatment in children with renal failure: Experience of the French Society of Pediatric Nephrology. Pediatr Nephrol 23:2031–2038

    Article  PubMed  Google Scholar 

  16. Tönshoff B. Growth hormone treatment in children with chronic kidney disease and post renal transplantation. https://www.uptodate.com/contents/growth-hormone-treatment-in-children-with-chronic-kidney-disease-and-postrenal-transplantation. Accessed 10 Aug 2016

  17. Hodson EM, Willis NS, Craig JC (2012) Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev 2:CD003264

    Google Scholar 

  18. Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German study Group for Growth Hormone Treatment in chronic renal failure. N Engl J Med 343:923–930

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Hospital Nacional de Pediatria J.P.Garrahan, C. de los Pozos 1881, C1245AAM, Buenos Aires, Argentina

    Silvia Gil, Mariana Aziz & Alicia Belgorosky

  2. Department of Nephrology, Hospital Nacional de Pediatria J.P.Garrahan, Buenos Aires, Argentina

    Marta Adragna & Marta Monteverde

  3. Consejo Nacional de Investigaciones Cientificas y Tecnicas (C.O.N.I.C.E.T), Buenos Aires, Argentina

    Alicia Belgorosky

Authors
  1. Silvia Gil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariana Aziz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marta Adragna
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marta Monteverde
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alicia Belgorosky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alicia Belgorosky.

Ethics declarations

Written informed consent was obtained from patients and their parents. The study was approved by the Medical Ethics Committee of Hospital de Pediatria J.P. Garrahan.

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gil, S., Aziz, M., Adragna, M. et al. Near-adult height in male kidney transplant recipients started on growth hormone treatment in late puberty. Pediatr Nephrol 33, 175–180 (2018). https://doi.org/10.1007/s00467-017-3777-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-017-3777-2

Keywords

Search

Navigation